Last Updated on November 12, 2021 by The Health Master
Download DMROA Act: Mumbai: Sewree Metropolitan Magistrate Court in Mumbai has imposed fines to the tune of Rs. 90,000 on four drug makers for putting in place labels on the drugs claiming to treat stopped menstrual cycles and respiratory systems as well as splashing advertisements for the same in violation of the Drugs and Magic Remedies (Objectionable Advertisement) Act, 1954.
‘To regulate menstrual cycle’ was printed on the label of ‘Gynoplus capsules’ drug. This advertisement violated the provisions of the Drugs and Magic Remedies (Objectionable Advertisement) Act 1954 and Rules, said joint commissioner, Maharashtra Food and Drugs Administration (FDA), Gaurishankar Byale.
The Act prohibits advertisements of drugs and remedies that claim to have magical properties, and makes doing so a cognizable offence. The law prohibits advertising of drugs and remedies for inducing miscarriage or preventing conception in women, improving or maintaining the capacity for sexual pleasure, correction of menstrual disorders, respiratory disorders, diabetes, heart diseases, among others.
Hence, drugs inspectors, Greater Mumbai -AA Raskar and PN Chavan filed two different cases in the Chief Metropolitan Magistrate Court, Sewree, Mumbai.
After trial, on October 22, 2021 the court had imposed a fine of Rs. 40,000 on Dilip Burani, owner of Nalco Biotech, Indore in two cases and a fine of Rs. 20,000 each to Gaurav Shah, owner of Crystal Healthcare, Mumbai and Devendra Khatri, owner of Loyd Pharmaceuticals, Indore, said Byale.
Nalco Biotech was the manufacturer of the product and Crystal Healthcare and Loyd Pharmaceuticals were marketers of the product.
Respiratory problems: In another incident, the label of the drug ‘Virulina powder’ and the website of the manufacturer claimed to cure respiratory problems. Hence, a case was filed in Sewree Court by DA Jadhav, the then drug inspector, he said.
Fine of Rs. 10,000: On September 24, 2021 the court imposed a fine of Rs. 10,000 to Anilkumar Sharma, owner of Natural Solutions, Nashik and Yogita Kelkar, owner of Yugandhar Pharma, Nashik each for dealing with the product.
Maharashtra FDA has decided to take stringent action against objectionable advertisement of drugs being published in print media, electronic media and product labels. The fine imposed by the court on drugmakers involved in violation of Drugs and Magic Remedies (Objectionable Advertisement) Act will deter others from making such attempts, stated Byale.
The FDA has identified over a hundred advertisements of different drugs and other products that have violated its regulations. It has identified these ads through its team set up for monitoring violations of the Drug and Magic Remedies (Objectionable Advertisement Act) 1954.
“The process of issuing notices under this Act has started. A supplementary list of violations is being prepared by the drug inspectors of the FDA to ensure that the practice of publishing misleading or objectionable advertisements is controlled, ” he added.
Molecular testing in guiding Blood Cancer treatment
No allopathic drug found in Jackfuit365 flour: Lab test
USFDA gives final nod to Zydus Cadila for Glycopyrrolate Injection
Oral and Nasal Vaccines for Covid are on horizon: WHO
CDSCO extends the timeline for licensing of these Medical Devices
Govt agrees with proposal to grant Jan Aushadhi license only to Registered Pharmacists
Kerala to prepare Pharmacy Graduates for multiple opportunities in Govt sector
Para 19 of DPCO: IDMA urges Govt to allow Pharma industry to hike Drugs prices
Latest on National Formulary of India (NFI)
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
